Sunday, August 11, 2024 9:00:18 AM
[this is not intended for reply to maverick but beartrap12]
What a hack you wrote, "I believe MHRA needs to see that our Flaskworks Eden units work before we get a green-light for MAA." You are totally out of bounds against all NWBio has stated so far and against a regulatory process which has been clearly specified.
Overly enthusiastic, cart before the horse is no less harmful than the short bizarre baseless slanders to the interests of NWBio, its investors and yourself as a long (maybe a radical long TO BE EXACT).
Please stop. Let the process play out according to the course. MHRA will approve MAA with manual manufacturing, then improved Eden systems will follow.
Unless you stated that on behalf of the company, preparing us for one more delay, which I don't think is the case, cause Linda though selfish and greedy is not that stupid.
So please all overly enthusiastic longs STOP!
What a hack you wrote, "I believe MHRA needs to see that our Flaskworks Eden units work before we get a green-light for MAA." You are totally out of bounds against all NWBio has stated so far and against a regulatory process which has been clearly specified.
Overly enthusiastic, cart before the horse is no less harmful than the short bizarre baseless slanders to the interests of NWBio, its investors and yourself as a long (maybe a radical long TO BE EXACT).
Please stop. Let the process play out according to the course. MHRA will approve MAA with manual manufacturing, then improved Eden systems will follow.
Unless you stated that on behalf of the company, preparing us for one more delay, which I don't think is the case, cause Linda though selfish and greedy is not that stupid.
So please all overly enthusiastic longs STOP!
Bullish
Recent NWBO News
- CNS Drug Delivery Breakthroughs Unlock Significant Biotech Market Opportunities • InvestorsHub NewsWire • 05/11/2026 01:00:00 PM
- CNS Drug Delivery Breakthroughs Unlock Significant Biotech Market Opportunities • GlobeNewswire Inc. • 05/11/2026 12:30:00 PM
- Northwest Biotherapeutics Appoints Dr. Annalisa Jenkins As Strategic Adviser To Advance Dendritic Cell Cancer Vaccine Platform • PR Newswire (US) • 04/30/2026 04:38:00 PM
- Northwest Biotherapeutics Appoints Dr. Annalisa Jenkins As Strategic Adviser To Advance Dendritic Cell Cancer Vaccine Platform • PR Newswire (US) • 04/30/2026 04:30:00 PM
- Northwest Biotherapeutics Announces Establishment Of the Company's Own Dedicated Leukapheresis Clinic • PR Newswire (US) • 04/21/2026 01:30:00 PM
- Northwest Biotherapeutics Announces Establishment Of the Company's Own Dedicated Leukapheresis Clinic • PR Newswire (US) • 04/21/2026 01:30:00 PM
- Form EFFECT - Notice of Effectiveness • Edgar (US Regulatory) • 04/21/2026 04:15:08 AM
- Form POS AM - Post-Effective amendments for registration statement • Edgar (US Regulatory) • 04/16/2026 09:25:30 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 04/07/2026 04:30:50 PM
- Form NT 10-K - Notification of inability to timely file Form 10-K 405, 10-K, 10-KSB 405, 10-KSB, 10-KT, or 10-KT405 • Edgar (US Regulatory) • 03/31/2026 09:04:37 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 01/15/2026 10:06:20 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 01/02/2026 10:14:59 PM
- Form DEF 14A - Other definitive proxy statements • Edgar (US Regulatory) • 11/28/2025 09:43:27 PM
- Form 424B5 - Prospectus [Rule 424(b)(5)] • Edgar (US Regulatory) • 11/25/2025 10:23:07 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 11/20/2025 09:26:03 PM
- Form PRE 14A - Other preliminary proxy statements • Edgar (US Regulatory) • 11/19/2025 09:15:48 PM
- Form 10-Q - Quarterly report [Sections 13 or 15(d)] • Edgar (US Regulatory) • 11/14/2025 09:44:21 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 10/31/2025 04:29:10 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 10/30/2025 08:40:05 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 10/24/2025 04:28:38 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 10/14/2025 06:22:26 PM
- Form 10-Q - Quarterly report [Sections 13 or 15(d)] • Edgar (US Regulatory) • 08/14/2025 09:00:38 PM
- Form 424B5 - Prospectus [Rule 424(b)(5)] • Edgar (US Regulatory) • 07/01/2025 09:04:38 PM
